Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer

Prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer

US Patent 8642270 · Granted Feb 4, 2014

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Generating customizable personal healthcare treatment plans2023
Inhibitors of pyruvate kinase as therapeutic agents for cancer2011
Methods of identifying modulators of a DP prostaglandin receptor2002
Methods of identifying modulators of human IP prostaglandin receptor2002
Methods of identifying modulators of a prostaglandin receptor2002
DNA encoding prostaglandin receptor DP2001
DNA encoding prostaglandin receptor DP1999
DNA encoding prostaglandin receptor FP1999
Purified prostaglandin receptor FP1998
Elisa kit for the rapid determination of N-acetyltransferase (NAT2) phenotypes1998
Prostaglandin receptor EP21998
Human Prostaglandin receptor IP1998